Variable
Prebariatric
Pre-abdominoplasty
Post-abdominoplasty
Significancea
BMI (kg/m2)
55.7 ± 13.0
31.9 ± 4.6
30.2 ± 3.7
p < 0.001
p = 0.424
Hemoglobin (g/dL)
12.5 ± 2.2
11.7 ± 1.7
11.8 ± 2.4
p = 0.161
p = 0.662
WBC (x103/mm3)
6.6 ± 1.6
5.0 ± 1.1
5.2 ± 1.4
p = 0.006
p = 0.277
Total cholesterol (mg/dL)
176 ± 41
183 ± 12
187 ± 35
p = 0.227
p = 0.246
HDL cholesterol (mg/dL)
51.4 ± 8.4
61.8 ± 6.7
72.6 ± 13.2
p = 0.041
p = 0.049
LDL cholesterol (mg/dL)
110 ± 38
107 ± 14
96.3 ± 14.8
p = 0.817
p = 0.256
VLDL cholesterol (mg/dL)
16.3 ± 3.5
12.3 ± 1.5
13.6 ± 3.7
p = 0.144
p = 0.257
Triglycerides (mg/dL)
80.8 ± 13.0
60.8 ± 6.7
73.8 ± 17.2
p = 0.041
p = 0.095
Glucose (mg/dL)
99.6 ± 26.6
83.5 ± 5.8
86.4 ± 6.5
p = 0.133
p = 0.555
HbA1c (%)
8.5 ± 2.8
5.7 ± 1.6
5.4 ± 1.1
p = 0.038
p = 0.223
C-reactive protein (mg/dL)
6.6 ± 3.3
3.9 ± 2.3
2.2 ± 1.6
p = 0.024
p = 0.008
The profile after mastopexy with breast implants revealed some unexpected alterations. These patients presented a lower BMI previous to bariatric and plastic surgeries, besides the sustained anemia in the years following breast reconstruction. On the other hand, a pattern of nutritional stability was presented during the observation period (Table. 31.2).
Table 31.2
Outcome variables in control patients (mastopexy with implants)
Variable | Prebariatric | Preimplant | Postimplant | Significancea | |
---|---|---|---|---|---|
BMI (kg/m2) | 43.7 ± 3.6 | 25.5 ± 2.2 | 24.6 ± 2.6 | p < 0.001 | p = 0.233 |
Hemoglobin (g/dL) | 13.2 ± 0.9 | 12.1 ± 1.0 | 11.0 ± 1.8 | p = 0.017 | p = 0.039 |
WBC (x103/mm3) | 7.3 ± 2.2 | 5.5 ± 1.3 | 5.5 ± 1.5 | p = 0.015 | p = 0.558 |
Total cholesterol (mg/dL) | 187 ± 31 | 151 ± 31 | 168 ± 35 | p = 0.004 | p = 0.167 |
HDL cholesterol (mg/dL) | 47.0 ± 9.9 | 69.4 ± 19.5 | 66.0 ± 4.1 | p = 0.040 | p = 0.869 |
LDL cholesterol (mg/dL) | 113 ± 23 | 70.8 ± 20.8 | 79.5 ± 25.9 | p = 0.006 | p = 0.161 |
VLDL cholesterol (mg/dL) | 21.1 ± 14.1 | 13.6 ± 6.1 | 15.0 ± 8.4 | p < 0.001 | p = 0.073 |
Triglycerides (mg/dL) | 159 ± 62 | 66.7 ± 21.3 | 75.3 ± 33.1 | p = 0.027 | p = 0.088 |
Glucose (mg/dL) | 90.4 ± 9.7 | 83.9 ± 9.4 | 88.3 ± 3.4 | p = 0.027 | p = 0.937 |
HbA1c (%) | 5.9 ± 0.3 | 5.9 ± 0.5 | 6.0 ± 0.6 | p = 0.874 | p = 0.667 |
C-reactive protein (mg/dL) | 6.8 ± 2.1 | 4.6 ± 5.7 | 3.2 ± 1.0 | p = 0.143 | p = 0.301 |
On Table 31.3, literature data are presented regarding the impact of liposuction and abdominoplasty in several metabolic variables.
Table 31.3
Metabolic evaluation after liposuction and abdominoplasty
Liposuction | Type | Follow-up | Response |
---|---|---|---|
14 overweight obese [27] | Large | 4 months | Insulin resistance improved, lipids unchanged |
45 obese [28] | Large | 6 months | Lipids, inflammation improved |
123 obese [29] | Large | 3 months | Insulin and inflammation improved |
15 obese [30] | Large | 6 months | Insulin resistance improved |
19 normal + obese [31] | Conv. | 6 months | Total cholesterol decreased, LDL increased |
15 overweight + obese [33] | Conv. |